Biotech Halftime Report: A Winding Road Ahead
Pathfinders in Biopharma - Een podcast door RBC Capital Markets
Categorieën:
Join Head of US Capital Markets Research, Mark Odendahl and biotech analysts Brian Abrahams and Gregory Renza, as they explore the dynamic biotech sector landscape in H2 2023. This episode was originally broadcast on Industries in Motion, the RBC podcast.
